NCT05381454View on ClinicalTrials.gov

An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 28, 2022

Primary Completion Date

May 9, 2023

Study Completion Date

May 9, 2023

Conditions
Respiratory Viral InfectionAntiviral TreatmentCOVID-19
Interventions
DRUG

Mitoquinone/mitoquinol mesylate

Mitoquinone/mitoquinol mesylate

Trial Locations (1)

75219

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER